Involvement of lips and gums in a borderline tuberculoid leprosy patient.
Mishra
B
B
Central JALMA Institute for Leprosy (ICMR), Tajganj, Agra.
Mukherjee
A
A
Girdhar
A
A
Husain
S
S
Malaviya
G N
GN
Girdhar
B K
BK
D002648:Child; D003622:Dapsone / Q000627:therapeutic use; D005260:Female; D005882:Gingival Diseases / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use; D015439:Leprosy, Borderline / Q000150:complications* / Q000188:drug therapy; D008047:Lip Diseases / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D012293:Rifampin / Q000627:therapeutic use
D007917:Leprostatic Agents; D003622:Dapsone; D012293:Rifampin